Jeffrey Calabrese is Vice President of Finance of AERIE PHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of AERI, which is worth approximately $0. The most recent transaction as insider was on Nov 21, 2022, when has been sold 18,585 shares (Common Stock) at a price of $15.25 per share, resulting in proceeds of $283,421. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Jeffrey Calabrese Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 21 2022
SELL
Sale (or disposition) back to the issuer
$283,421 $15.25 p/Share
18,585 Reduced 100.0%
0 Common Stock
Nov 01 2022
SELL
Payment of exercise price or tax liability
$2,724 $15.22 p/Share
179 Reduced 0.95%
18,585 Common Stock
Aug 14 2022
SELL
Payment of exercise price or tax liability
$3,066 $11.57 p/Share
265 Reduced 1.39%
18,764 Common Stock
Jul 01 2022
SELL
Payment of exercise price or tax liability
$2,224 $8.36 p/Share
266 Reduced 1.38%
19,029 Common Stock
Jul 01 2022
BUY
Grant, award, or other acquisition
-
11,276 Added 36.88%
19,295 Common Stock
JC

Jeffrey Calabrese

Vice President of Finance
Durham, NC

Track Institutional and Insider Activities on AERI

Follow AERIE PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AERI shares.

Notify only if

Insider Trading

Get notified when an Aerie Pharmaceuticals Inc insider buys or sells AERI shares.

Notify only if

News

Receive news related to AERIE PHARMACEUTICALS INC

Track Activities on AERI